Delarosa v. Boiron, Inc.
275 F.R.D. 582
C.D. Cal.2011Background
- Gina Delarosa filed a Motion for Class Certification; Boiron objected and separately moved to strike declarations. Denied as moot, class certification granted. Coldcalm is a homeopathic product marketed to relieve cold symptoms. Plaintiff alleges misrepresentations on packaging/website and seeks to represent California purchasers over four years. Plaintiff asserts three claims: CLRA, common-law fraud, and UCL, seeking injunctive and monetary relief. Court addresses standing, then Rule 23 requirements, and class notice plan.
- Plaintiff's and class members relied on Coldcalm's claimed efficacy; Plaintiff alleges economic injury due to misrepresentation and seeks to certify a California-domiciled class of personal-use purchasers.
- Court treats three claims as interrelated for commonality/typicality purposes and determines standing for UCL and CLRA; class certification and notice plan are discussed with respect to Rule 23(b)(2) and 23(b)(3).
- The Court finds standing for UCL and CLRA claims; the class includes all California residents who purchased Coldcalm for personal use in the four years preceding the complaint.
- Rules and standards for class certification are applied, with an emphasis on the predominance/superiority under Rule 23(b)(3) and injunctive relief under Rule 23(b)(2).
- Final certification order grants class status, appoints plaintiffs as class representative and class counsel, and directs notice planning to include rights to opt out/intervene.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Standing for UCL/CLRA claims | Delarosa has injury in fact from misrepresentation; class members similarly harmed. | No independent proof of class members' reliance; lack of standing for absent members. | Plaintiff has standing for UCL/CLRA; absent class members have inferred reliance via material misrepresentation. |
| Commonality under Rule 23(a)(2) | Common misrepresentation about Coldcalm's efficacy affects all class members. | Evidence may vary per member; reliance issues differ. | Common questions predominate; misrepresentation about efficacy is a common contention. |
| Typicality under Rule 23(a)(3) | Delarosa and her minor children are representative of class injuries. | Plaintiff may differ in sickness or purchase specifics; lacks typicality. | Delarosa's claims are typical for the class; guardian can sue on behalf of minors under Rule 17(a)(1)(C). |
| Representative Parties and Adequacy under Rule 23(a)(4) | Plaintiff has uniform claims; counsel experienced in class actions. | Plaintiff may lose CLRA damages; credibility concerns. | Plaintiff and counsel are adequate to represent the class. |
| Rule 23(b)(2) and Rule 23(b)(3) certification | Injunctive relief appropriate; monetary relief may be incidental. | Incidental damages may not align with 23(b)(2) limits; senior-damages issue problematic. | 23(b)(2) certified for injunctive and incidental damages; 23(b)(3) certified for the broader class; punitive/other damages analyzed as incidental where appropriate. |
Key Cases Cited
- In re Tobacco II Cases, 46 Cal.4th 298 (Cal. 2009) (standing under UCL requires actual reliance for fraud prong; material misrepresentation supports reliance inference)
- Steroid Hormone Prod. Cases, 181 Cal.App.4th 145 (Cal. App. 2010) (actual reliance element; material misrepresentation supports standing)
- Stearns v. Ticketmaster Corp., 655 F.3d 1013 (9th Cir. 2011) (common questions and class treatment of damages under 23(b)(3))